Larvol Delta - Viracta-Therapeutics-Announces-Positive-Data-from-the-Phase-2-NAVAL1-Trial-Regulatory-Progress-and-Updated-Nanaval-Clinical-Development-Plan

Valcyte (valganciclovir) - Roche, Mitsubishi Tanabe

nanatinostat (VRx-3996) - Viracta Therap

https://www.globenewswire.com/news-release/2024/08/14/2929921/0/en/Viracta-Therapeutics-Announces-Positive-Data-from-the-Phase-2-NAVAL-1-Trial-Regulatory-Progress-and-Updated-Nana-val-Clinical-Development-Plan.html

Aug 14, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next